203 related articles for article (PubMed ID: 15253187)
1. Occult breast carcinoma in reduction mammaplasty specimens: 14-year experience.
Colwell AS; Kukreja J; Breuing KH; Lester S; Orgill DP
Plast Reconstr Surg; 2004 Jun; 113(7):1984-8. PubMed ID: 15253187
[TBL] [Abstract][Full Text] [Related]
2. Incidence of occult contralateral carcinomas of the breast following mastoplasty aimed at symmetrization.
Sorin T; Fyad JP; Pujo J; Colson T; Bordes V; Leroux A; Marchal F; Brix M; Simon E; Verhaeghe JL; Classe JM; Dolivet G
Ann Chir Plast Esthet; 2014 Apr; 59(2):e21-8. PubMed ID: 24530086
[TBL] [Abstract][Full Text] [Related]
3. Occult carcinoma in 866 reduction mammaplasties: preserving the choice of lumpectomy.
Slezak S; Bluebond-Langner R
Plast Reconstr Surg; 2011 Feb; 127(2):525-530. PubMed ID: 21285757
[TBL] [Abstract][Full Text] [Related]
4. A Risk-Stratified Comparison of High-Risk Findings in Reduction Mammoplasty.
Dreifuss SE; Landfair AS; De La Cruz C
Ann Plast Surg; 2018 Jul; 81(1):36-38. PubMed ID: 29762441
[TBL] [Abstract][Full Text] [Related]
5. Carcinoma and atypical hyperplasia in reduction mammaplasty: increased sampling leads to increased detection. A prospective study.
Ambaye AB; MacLennan SE; Goodwin AJ; Suppan T; Naud S; Weaver DL
Plast Reconstr Surg; 2009 Nov; 124(5):1386-1392. PubMed ID: 20009822
[TBL] [Abstract][Full Text] [Related]
6. Breast cancer in reduction mammaplasty specimens: case reports and guidelines.
Keleher AJ; Langstein HN; Ames FC; Ross MI; Chang DW; Reece GP; Singletary SE
Breast J; 2003; 9(2):120-5. PubMed ID: 12603386
[TBL] [Abstract][Full Text] [Related]
7. Recommendations for Pathologic Evaluation of Reduction Mammoplasty Specimens: A Prospective Study With Systematic Tissue Sampling.
Ambaye AB; Goodwin AJ; MacLennan SE; Naud S; Weaver DL
Arch Pathol Lab Med; 2017 Nov; 141(11):1523-1528. PubMed ID: 28795842
[TBL] [Abstract][Full Text] [Related]
8. Incidental atypical proliferative lesions in reduction mammoplasty specimens: analysis of 2498 cases from 2 tertiary women's health centers.
Desouki MM; Li Z; Hameed O; Fadare O; Zhao C
Hum Pathol; 2013 Sep; 44(9):1877-81. PubMed ID: 23656973
[TBL] [Abstract][Full Text] [Related]
9. Incidental breast carcinoma in reduction mammoplasty.
Huysmans M; Bronckaers M; Schillebeeckx C; Servaes D
Acta Chir Belg; 2017 Oct; 117(5):308-311. PubMed ID: 28610472
[TBL] [Abstract][Full Text] [Related]
10. The Incidence of Occult Malignant and High-Risk Pathologic Findings in Breast Reduction Specimens.
Razavi SA; Hart AM; Betarbet U; Li X; Carlson GW; Losken A
Plast Reconstr Surg; 2021 Oct; 148(4):534e-539e. PubMed ID: 34550926
[TBL] [Abstract][Full Text] [Related]
11. Contralateral mastoplasty for breast reconstruction: a good opportunity for glandular exploration and occult carcinomas diagnosis.
Petit JY; Rietjens M; Contesso G; Bertin F; Gilles R
Ann Surg Oncol; 1997 Sep; 4(6):511-5. PubMed ID: 9309343
[TBL] [Abstract][Full Text] [Related]
12. Frequency of clinically occult intraepithelial and invasive neoplasia in reduction mammoplasty specimens: a study of 516 cases.
Dotto J; Kluk M; Geramizadeh B; Tavassoli FA
Int J Surg Pathol; 2008 Jan; 16(1):25-30. PubMed ID: 18203780
[TBL] [Abstract][Full Text] [Related]
13. The Management of Breast Cancer Detected by Reduction Mammaplasty.
Carlson GW
Clin Plast Surg; 2016 Apr; 43(2):341-7. PubMed ID: 27012792
[TBL] [Abstract][Full Text] [Related]
14. A Comparative Retrospective Analysis of Complications After Oncoplastic Breast Reduction and Breast Reduction for Benign Macromastia: Are These Procedures Equally Safe?
Imahiyerobo TA; Pharmer LA; Swistel AJ; Talmor M
Ann Plast Surg; 2015 Oct; 75(4):370-5. PubMed ID: 24691307
[TBL] [Abstract][Full Text] [Related]
15. Occult Breast Carcinoma Is More Common in Women Undergoing Breast Reduction after Contralateral Cancer: A Systematic Review and Meta-Analysis.
Fitzpatrick SE; Lam TC
Plast Reconstr Surg; 2020 Aug; 146(2):117e-126e. PubMed ID: 32740565
[TBL] [Abstract][Full Text] [Related]
16. Proliferative Lesions Found at Reduction Mammaplasty: Incidence and Implications in 995 Breast Reductions.
Mastroianni M; Lin A; Hughes K; Colwell AS
Plast Reconstr Surg; 2019 Feb; 143(2):271e-275e. PubMed ID: 30489497
[TBL] [Abstract][Full Text] [Related]
17. Incidental atypical proliferative lesions in reduction mammoplasty specimens in patients with a history of breast cancer.
Li Z; Fadare O; Hameed O; Zhao C; Desouki MM
Hum Pathol; 2014 Jan; 45(1):104-9. PubMed ID: 24182561
[TBL] [Abstract][Full Text] [Related]
18. Occult breast carcinoma in patients undergoing reduction mammaplasty.
Gottlieb JR; McKinney P; Walkinshaw MD; Sperling RL
Aesthetic Plast Surg; 1989; 13(4):279-83. PubMed ID: 2556896
[TBL] [Abstract][Full Text] [Related]
19. Histopathological findings in surgical specimens obtained from reduction mammaplasties.
Viana GA; Pitanguy I; Torres E
Breast; 2005 Jun; 14(3):242-8. PubMed ID: 15927834
[TBL] [Abstract][Full Text] [Related]
20. Intra-operative digital specimen radiology reduces re-operation rates in therapeutic mammaplasty for breast cancer.
Majdak-Paredes EJ; Schaverien MV; Szychta P; Raine C; Dixon JM
Breast; 2015 Oct; 24(5):556-9. PubMed ID: 26119619
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
